Dispensing fees for medication assisted treatment for opioid dependence (MATOD) are inequitable and create a major barrier to treatment access, retention and optimal outcomes. State and/or federal governments must address the issue of dispensing fees and implement a more equitable system of payment in order to support MATOD clients and in particular disadvantaged clients and those on low or fixed incomes